From: CDER DRUGINFO
Sent: Monday, December 22, 2003 10:10 AM
To: Dockets, FDA
Subject: FW: FDA Comments



-----Original Message-----
From: dale.hawaii@usa.com [mailto:dale.hawaii@usa.com]
Sent: Monday, December 22, 2003 1:35 AM
To: druginfo@cder.fda.gov
Subject: FDA Comments




  Name: Bonnie and Dale Dudas

  E-Mail: dale.hawaii@usa.com

  Comments: we cannot respond in time to your Dec 22nd deadline by mail, so we're letting you know we're in 100% agreement with the letter below. We would be happy to provide additional testimonial information.

This letter was written to the FDA on 3 Dec 2003:
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration 
[Docket No. 2003D-0478]
Draft Guidance on Marketed Unapproved Drugs; Compliance Policy
Guide; Availability
AGENCY Food and Drug Administration, HHS.
ACTION Notice.
To Whom This May Concern, 
Response to: 2003D-0478; Draft Guidance on Marketed Unapproved Drugs Compliance Policy Guide; Availability 10/20/03 12/22/03
 
(body of letter ommitted due to length)

Yours sincerely,
The International Guai-Support Group Network
Kathleen Shuller
Guai-Support Representative
Panama City Fl

Sincerely,  Bonnie and Dale Dudas - Honolulu, HI